The use of brain-machine interface, motor imagery, and action observation in the rehabilitation of individuals with Parkinson’s disease: A protocol study for a randomized clinical trial

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One vol. 20, no. 4 (Apr 2025), p. e0315148
Autor principal: Kátine Marchezan Estivalet
Otros Autores: Tatiana Salayaran de Aguiar Pettenuzzo, Natália Lopes Mazzilli, Ferreira, Luis Fernando, Cechetti, Fernanda
Publicado:
Public Library of Science
Materias:
Acceso en línea:Citation/Abstract
Full Text
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nab a2200000uu 4500
001 3187475430
003 UK-CbPIL
022 |a 1932-6203 
024 7 |a 10.1371/journal.pone.0315148  |2 doi 
035 |a 3187475430 
045 2 |b d20250401  |b d20250430 
084 |a 174835  |2 nlm 
100 1 |a Kátine Marchezan Estivalet 
245 1 |a The use of brain-machine interface, motor imagery, and action observation in the rehabilitation of individuals with Parkinson’s disease: A protocol study for a randomized clinical trial 
260 |b Public Library of Science  |c Apr 2025 
513 |a Evidence Based Healthcare Journal Article 
520 3 |a BackgroundParkinson’s disease (PD) is a neurodegenerative condition that impacts motor planning and control of the upper limbs (UL) and leads to cognitive impairments. Rehabilitation approaches, including motor imagery (MI) and action observation (AO), along with the use of brain-machine interfaces (BMI), are essential in the PD population to enhance neuroplasticity and mitigate symptoms.ObjectiveTo provide a description of a rehabilitation protocol for evaluating the effects of isolated and combined applications of MI and action observation (AO), along with BMI, on upper limb (UL) motor changes and cognitive function in PD.MethodsThis study provides a detailed protocol for a single-blinded, randomized clinical trial. After selection, participants will be randomly assigned to one of five experimental groups. Each participant will be assessed at three points: pre-intervention, post-intervention, and at a follow-up four weeks after the intervention ends. The intervention consists of 10 sessions, each lasting approximately 60 minutes.Expected resultsThe primary outcome expected is an improvement in the Test d’Évaluation des Membres Supérieurs de Personnes Âgées score, accompanied by a reduction in task execution time. Secondary outcomes include motor symptoms in the upper limbs, assessed via the Unified Parkinson’s Disease Rating Scale - Part III and the 9-Hole Peg Test; cognitive function, assessed with the PD Cognitive Rating Scale; and occupational performance, assessed with the Canadian Occupational Performance Measure.DiscussionThis study protocol is notable for its intensive daily sessions. Both MI and AO are low-cost, enabling personalized interventions that physiotherapists and occupational therapists can readily replicate in practice. While BMI use does require professionals to acquire an exoskeleton, the protocol ensures the distinctiveness of the interventions and, to our knowledge, is the first to involve individuals with PD.Trial registrationClinicalTrials.gov NCT05696925. 
610 4 |a University of Health Sciences 
651 4 |a Montreal Quebec Canada 
651 4 |a Canada 
653 |a Cognitive ability 
653 |a Memory 
653 |a Brain research 
653 |a Signs and symptoms 
653 |a Intervention 
653 |a Questionnaires 
653 |a Mental task performance 
653 |a Motor ability 
653 |a Brain 
653 |a Task analysis 
653 |a Rehabilitation 
653 |a Exoskeleton 
653 |a Health sciences 
653 |a Ethics 
653 |a Neurodegenerative diseases 
653 |a Parkinson's disease 
653 |a Motor task performance 
653 |a Limbs 
653 |a Movement disorders 
653 |a Neuroplasticity 
653 |a Man-machine interfaces 
653 |a Confidentiality 
653 |a Clinical trials 
653 |a Data collection 
653 |a Exoskeletons 
653 |a Imagery 
653 |a Social 
700 1 |a Tatiana Salayaran de Aguiar Pettenuzzo 
700 1 |a Natália Lopes Mazzilli 
700 1 |a Ferreira, Luis Fernando 
700 1 |a Cechetti, Fernanda 
773 0 |t PLoS One  |g vol. 20, no. 4 (Apr 2025), p. e0315148 
786 0 |d ProQuest  |t Health & Medical Collection 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3187475430/abstract/embedded/J7RWLIQ9I3C9JK51?source=fedsrch 
856 4 0 |3 Full Text  |u https://www.proquest.com/docview/3187475430/fulltext/embedded/J7RWLIQ9I3C9JK51?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3187475430/fulltextPDF/embedded/J7RWLIQ9I3C9JK51?source=fedsrch